ARTV Award Disclosure
Hougen Elizabeth L · SEC Form 4 · Filed Sep 8, 2026
Award
Calculated transaction value
$0
Hougen Elizabeth L Director
ARTV
Transaction date
Sep 8, 2026
Public filing date
Sep 8, 2026
Filing lag
Filed same day
ARTV daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Director Stock Option (Right to Buy) on Common Stock
- Quantity / price
- 13,750 shares @ $0
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0001193125-26-385416
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Artiva Biotherapeutics, Inc. ARTV Current | Award | Sep 8, 2026 | $0 |